Amvuttra (vutrisiran)

pCPA File Number: 23460

Negotiation Status:

Under consideration for negotiation

Indication(s):

Cardiomyopathy due to transthyretin-mediated amyloidosis

Sponsor/Manufacturer:

Alnylam Netherlands B.V.

CDA-AMC Project Number:

SR0904-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable